Asthma Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Asthma stocks.

Asthma Stocks Recent News

Date Stock Title
Jun 15 AZN AstraZeneca: The Price Upside Is Exhausted For Now (Rating Downgrade)
Jun 14 REGN Regeneron Pharmaceuticals Wins Injunctions Against Biosimilars to Eye Disease Drug Eylea
Jun 14 REGN Regeneron wins injunction blocking Samsung Bioepis from launching generic Eylea
Jun 14 TEVA Teva accuses Corcept of monopolizing the market for Korlym
Jun 14 AZN Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Jun 14 AZN Pharma Stock Roundup: FDA Panel Endorses LLY's Donanemab, PFE's DMD Therapy Study Fails
Jun 14 TMO Thermo Fisher's (TMO) New Launch Supports Full Lab Automation
Jun 14 REGN Investors in Regeneron Pharmaceuticals (NASDAQ:REGN) have seen stellar returns of 220% over the past five years
Jun 13 TEVA Teva sues Corcept over mifepristone 'monopoly' for rare disorder
Jun 13 AZN AstraZeneca CFO: 'We've come a long way in our oncology portfolio'
Jun 13 AZN FDA Expands AstraZeneca's (AZN) Farxiga Label in Pediatric T2D
Jun 13 REGN Why It's A New Day For COPD Patients — And Regeneron, Sanofi, Verona Stocks
Jun 13 VRNA Why It's A New Day For COPD Patients — And Regeneron, Sanofi, Verona Stocks
Jun 13 AZN Why It's A New Day For COPD Patients — And Regeneron, Sanofi, Verona Stocks
Jun 13 TMO Investors in Thermo Fisher Scientific (NYSE:TMO) have seen respectable returns of 99% over the past five years
Jun 13 AZN FDA approves AstraZeneca’s Farxiga for paediatric T2D patients
Jun 13 REGN REGN, CI, BSX: Which “Strong Buy” Healthcare Stock Is the Best Bet?
Jun 12 CNTB Connect Biopharma Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Jun 12 CNTB Connect Biopharma appoints Barry Quart as CEO
Jun 12 AZN FARXIGA approved in the US for the treatment of pediatric type-2 diabetes
Asthma

Asthma is a common long-term inflammatory disease of the airways of the lungs. It is characterized by variable and recurring symptoms, reversible airflow obstruction, and bronchospasm. Symptoms include episodes of wheezing, coughing, chest tightness, and shortness of breath. These episodes may occur a few times a day or a few times per week. Depending on the person, they may become worse at night or with exercise.Asthma is thought to be caused by a combination of genetic and environmental factors. Environmental factors include exposure to air pollution and allergens. Other potential triggers include medications such as aspirin and beta blockers. Diagnosis is usually based on the pattern of symptoms, response to therapy over time, and spirometry. Asthma is classified according to the frequency of symptoms, forced expiratory volume in one second (FEV1), and peak expiratory flow rate. It may also be classified as atopic or non-atopic, where atopy refers to a predisposition toward developing a type 1 hypersensitivity reaction.There is no cure for asthma. Symptoms can be prevented by avoiding triggers, such as allergens and irritants, and by the use of inhaled corticosteroids. Long-acting beta agonists (LABA) or antileukotriene agents may be used in addition to inhaled corticosteroids if asthma symptoms remain uncontrolled. Treatment of rapidly worsening symptoms is usually with an inhaled short-acting beta-2 agonist such as salbutamol and corticosteroids taken by mouth. In very severe cases, intravenous corticosteroids, magnesium sulfate, and hospitalization may be required.In 2015, 358 million people globally had asthma, up from 183 million in 1990. It caused about 397,100 deaths in 2015, most of which occurred in the developing world. It often begins in childhood. The rates of asthma have increased significantly since the 1960s. Asthma was recognized as early as Ancient Egypt. The word "asthma" is from the Greek ἅσθμα, ásthma, which means "panting".

Browse All Tags